Prior therapies have focused on effects, not on causes. They have tried to help symptoms or wished to remove amyloid or tau proteins.

Telocyte
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.telocyte.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address250 Monroe Ave NW, MI, 49503Grand RapidsUnited States
250 Monroe Ave NW, MI, 49503
Grand Rapids
United States
Contact Number+1 616-570-4515
+1 616-570-4515
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/telocyte” connections=”true” suffix=””]